Petriage’s Pet Symptom Analysis tool uses a cloud-based system to help clients determine urgency of their pet’s symptoms and the need to seek veterinary care.
Petriage, a B2B pet health technology company, announced that the US Patent and Trademark Office issued them an industry-first patent for their Pet Symptom Analysis tool.
This teletriage app utilizes artificial intelligence (AI) to help clients (with 97%-plus accuracy) assess the need for veterinary care for ill pets. It also offers users free 24/7 access to the pet symptom checker. Additionally, the app allows owners to remotely engage with their veterinarian and make payments with ease.
“The pet symptom checker 'thinks' like a veterinarian reviewing a sick pet’s complaints,” says Petriage’s Chief Strategy Officer Allon Freiman, in a company release. “What’s more, with the machine learning component, Petriage continues to 'learn' and will have richer and richer data to draw upon with each additional use of the app.”
The symptom checker, which was patent-pending, was assigned US Patent No. 10,930,401, entitled “Pet Evaluation and Triage System,” protecting the company’s innovative technology and investments for 20 years from its priority date. The patent also covers all technology invented by Petriage cofounders and the principal product owner.
"This patent, Petriage's first underscores how our state-of-the-art technology is transforming vet clinics' patient care, profitability, and productivity while improving the quality of life for vets and their staffs," said Petriage CEO Joseph Coury, in the release. "We're pleased that one of our core technologies has received patent protection, an important step as we continue to enhance our platform with new features."
The company says it is also developing additional telehealth technology and services, including wearables and enhanced data analytics capabilities.
To learn more about the Pet Symptom Analysis app, go here.
Size of Phoenix pharmacy compounding facility has nearly doubled
December 11th 2024Covetrus announced the expansion of its' site in Arizona, increasing the company’s pharmacy capabilities for producing compounded products for use in veterinary clinics and pet owners' homes throughout the US
Read More